Among these 87 patients, FOXK1 or FHL2 expression in tumour samples was found to be significantly correlated with tumour differentiation, lymph node metastasis, TNM stage, serosal invasion and tumour size; however, it was not correlated with gender, age or location (Supplementary Table 1). Here, FHL2 is linked to neoplasm.